Cite
HARVARD Citation
Mehrotra, D. et al. (2017). Enabling robust assessment of QTc prolongation in early phase clinical trials. Pharmaceutical statistics. pp. 218-227. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mehrotra, D. et al. (2017). Enabling robust assessment of QTc prolongation in early phase clinical trials. Pharmaceutical statistics. pp. 218-227. [Online].